Insulet Corp (STU:GOV)
€ 228.1 5 (2.24%) Market Cap: 17.41 Bil Enterprise Value: 17.87 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 93/100

Insulet Corp at Guggenheim Partners MedTech Disrupters Summit Transcript

May 29, 2019 / 01:10PM GMT
Release Date Price: €94.06 (-2.70%)
Unidentified Analyst

Okay. And we're going to roll right into our next presentation. So coming to the stage now from Insulet is Doctor Trang Ly. Thank you very much for joining us.

So advance, and we also have release report [to be exact].

Trang Ly
Insulet Corporation - Senior VP & Medical Director

Okay, great. Just push that down, so they can see me.

Okay, great. Good morning, ladies and gentlemen, I'm Dr. Trang Ly. I'm Senior Vice President and Medical Director at Insulet. We're the makers of the Omnipod tubeless insulin pump. Before I joined Insulet, I was at Stanford University in clinical practice and research. My research focus was in closed-loop technologies, and I've been with the company for the last 2.5 years, and I lead the critical function at Insulet.

Can I just have the show of hands for people in the audience who either know someone or has Type 1 diabetes? Oh wow, that's actually a much higher percentage in -- of the audience than I was expecting. And I think that until you know or have lived with diabetes, it's very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot